Please login to the form below

Not currently logged in
Email:
Password:

Jazz

This page shows the latest Jazz news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

Rounding out the new medicines approval was Jazz Pharmaceutical’s Sunosi (solriamfetol), which gained a positive opinion for the treatment of excessive daytime sleepiness in patients with narcolepsy, a sleep disorder

Latest news

More from news
Approximately 3 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    Finally it is always encouraging to see medium size companies like Mundipharma and Jazz finding and licensing new product opportunities. ... 250+. Immunogen (US). Jazz (IE, US). Collaboration and option. Phase I haematology-related antibody-drug

  • Deal Watch July 2016 Deal Watch July 2016

    Jazz Pharmaceuticals paid $15m in upfront and option payments to Pfenex for the rights to a portfolio of early stage products in haematology/oncology. ... Pfenex is a biosimilars company, and the agreement with Jazz also includes rights to a recombinant

  • Deal Watch May 2016 Deal Watch May 2016

    2, 000. Celator/ Jazz. Corporate acquisition. Acquisition for $30.25 per share brings Vyxeos [nano scale liposomal formulation of cytarabine /daunorubicin] for AML, completed P3.

  • Pharma deals in March 2015 Pharma deals in March 2015

    The other deal of interest is the re-emergence of EUSA Pharma with products acquired from Jazz Pharmaceuticals. ... investor, Essex Woodlands, has bought back products worth $27m and the EUSA Pharma name from Jazz for an undisclosed amount.

  • Pharma deals during September 2014 Pharma deals during September 2014

    2011. Alkermes. Elan. Ireland. 2012. Jazz. Azur. Ireland. 2013. Liberty Global.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics